You are browsing the global website, which contains information intended for residents outside of the United States of America (U.S.). This website is not country-specific and therefore may contain information that is not applicable to your country.
Rare Cells, with Single Cell Precision
We offer a menu of FDA-cleared and laboratory-developed tests (LDTs) used to detect and analyze circulating tumor cells in human blood with CELLSEARCH®. This minimally invasive liquid biopsy approach allows these tests to enable optimized patient care and comfort throughout the patient’s therapeutic journey.
Learn more about our Oncology portfolio
Learn more about our commitment in cell-based noninvasive prenatal testing (CB-NIPT)
Find out more about billing options
Learn more about setting up your account and ordering a test
If you already have an existing portal account, you can login here
Discover how our clinical lab service can support biopharma partners and clinical trials
Discover how our custom research lab service can support research projects
Single Cell Analysis
FFPE Analysis
View our complete list of Laboratory Developed Tests
Read the latest news from the Menarini Group
January 25 - 27, 2024 Santiago de Compostela, Spain Congress Website
February 27 - 29, 2024 Dublin, Ireland Congress Website
February 28 - March 1, 2024 San Diego, CA Congress Website
April 5 - 10, 2024 San Diego, CA Congress Website
May 15 - 17, 2024 Berlin, Germany Congress Website
May 21 - 24, 2024 Santorini, Greece Congress Website
May 24 - 25, 2024 Granada, Spain Congress Website
May 31 - June 4, 2024 Chicago, IL Congress Website
June 10 - 13, 2024 Rotterdam, Netherlands Congress Website
September 25 – 28, 2024 Rio de Janeiro, Brazil Congress Website
October 23 – 25, 2024 London, UK Congress Website
November 12 - 14, 2024 Lyon, France Congress Website
November 23 - 25, 2024 Denver, CO Congress Website
December 7 - 10, 2024 San Diego, CA Congress Website
December 10 - 14, 2024 San Antonio, TX Congress Website
Read More
Login